FDA Adverse Event Injury Summary report: N

OXF PKS ANAT MEN BRG UHMWPE RT SML SZ 3

MDR report key: 3870667 · Received June 12, 2014

Report

Report Number
3002806535-2014-00147
Event Type
Injury
Date Received
June 12, 2014
Date of Event
May 15, 2014
Report Date
September 4, 2014
Manufacturer
BIOMET UK LTD.
Product Code
NRA
PMA / PMN Number
PP010014
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AN OXFORD PARTIAL KNEE REPLACEMENT WAS REVISED AFTER APPROXIMATELY ONE YEAR AND NINE MONTHS. THE RETURNED FEMORAL COMPONENT AND TIBIAL TRAY SHOW EVIDENCE OF METAL-ON-METAL CONTACT, WHICH MAY HAVE CONTRIBUTED TO THE METALLOSIS FOUND WITHIN THE JOINT UPON REVISION. IT IS NOT KNOWN HOW THIS METAL-ON-METAL CONTACT MAY HAVE OCCURRED, HOWEVER IT IS POSSIBLE THAT THE MENISCAL BEARING MAY HAVE DISLOCATED AT SOME TIME DURING SERVICE. THE MENISCAL BEARING ITSELF WAS RECEIVED IN GOOD CONDITION WITH VERY FEW SIGNS OF WEAR AND THEREFORE THE MECHANISM OF PROPOSED DISLOCATION IS NOT CLEAR. THE EXACT CAUSE FOR THE PATIENT¿S PAIN AND ULTIMATE CAUSE FOR REVISION CANNOT BE DETERMINED.

Additional Manufacturer Narrative · 1

THE USER FACILITY IS OUTSIDE OF THE UNITED STATES. NO MEDWATCH REPORT WAS RECEIVED. NO PRODUCT WAS RETURNED. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE EVENT. NO FURTHER COMPLICATIONS HAVE BEEN REPORTED. PRODUCT TO BE RETURNED. UPON RECEIPT OF PRODUCT AND COMPLETION OF EVALUATION, AN MDR FOLLOW-UP REPORT WILL BE SENT TO THE FDA.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT UNDERWENT OXFORD KNEE SURGERY ON (B)(6) 2012. REVISION PROCEDURE WAS PERFORMED ON (B)(6) 2014 DUE TO PAIN AND METALLOSIS. NO FURTHER INFORMATION HAS BEEN RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
347865 OXF PKS ANAT MEN BRG UHMWPE RT SML SZ 3 PROSTHESIS, KNEE NRA BIOMET UK LTD. N/A 2185341

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R